Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment
- Supplementary File 1:
ZIP-Document (ZIP, 1586 KiB)
Trushina, D.B.; Sapach, A.Y.; Burachevskaia, O.A.; Medvedev, P.V.; Khmelenin, D.N.; Borodina, T.N.; Soldatov, M.A.; Butova, V.V. Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment. Pharmaceutics 2022, 14, 1325. https://doi.org/10.3390/pharmaceutics14071325
Trushina DB, Sapach AY, Burachevskaia OA, Medvedev PV, Khmelenin DN, Borodina TN, Soldatov MA, Butova VV. Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment. Pharmaceutics. 2022; 14(7):1325. https://doi.org/10.3390/pharmaceutics14071325
Chicago/Turabian StyleTrushina, Daria B., Anastasiia Y. Sapach, Olga A. Burachevskaia, Pavel V. Medvedev, Dmitry N. Khmelenin, Tatiana N. Borodina, Mikhail A. Soldatov, and Vera V. Butova. 2022. "Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment" Pharmaceutics 14, no. 7: 1325. https://doi.org/10.3390/pharmaceutics14071325